ORLANDO, FL, USA (UroToday.com) - Second-line chemotherapy agents for patients with platinum-refractory metastatic urothelial cancer (UC) are associated with low response rated and short progression-free and overall survival rates.
Your session will expire in 8 hours requiring you to log in each day to view content.